A panel of expert advisers to the U.S. Food and Drug Administration on Friday voted in favor of authorizing Johnson & Johnson’s one-dose COVID-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout. The FDA is likely to authorize the vaccine for emergency use within a day or so, making…